Alcon will officially leave Novartis on April 9 after an 8-year run. What's next?

22nd March 2019 Uncategorised 0

Exactly eight years into its full ownership of Alcon, Novartis will officially say goodbye to the eye care business on April 9. The spinoff follows Novartis’ recent sale of its stake in a GlaxoSmithKline consumer joint venture and some Sandoz generics.

More: Alcon will officially leave Novartis on April 9 after an 8-year run. What's next?
Source: fierce